Insmed Drug Wins First US Approval for Debilitating Lung Disease

Insmed Drug Wins First US Approval for Debilitating Lung Disease



Insmed Drug Wins First US Approval for Debilitating Lung Disease
US regulators have approved the first drug to treat a debilitating lung condition, ending two centuries of waiting and paving the way for a potential blockbuster from Insmed Inc.


www.bloomberg.com
#Insmed #Drug #Wins #Approval #Debilitating #Lung #Disease

Share: X · Facebook · LinkedIn

Leave a Reply

Your email address will not be published. Required fields are marked *